Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X

Users Online : 6935

Original article / research
Table of Contents - Year : 2017 | Month : March | Volume : 11 | Issue : 3 | Page : FC01 - FC04

A Prospective Analysis of Drug Interactions in Patients of Intensive Cardiac Care Unit FC01-FC04

Shipra Jain, Pushpawati Jain, Kopal Sharma, Pushpendra Saraswat

Dr. Shipra Jain,
Assistant Professor, Department of Pharmacology, Mahatma Gandhi Medical College and Hospital, Jaipur-302022, Rajasthan, India.

Introduction: Drug-Drug Interaction (DDI) is a serious concern in cardiac patients due to polypharmacy.

Aim:The present study was aimed to identify the potential DDI among hospitalized cardiac patients and evaluate the mechanism and severity of such interactions.

Materials and Methods: A prospective observational study was conducted in intensive cardiac care unit of a tertiary care hospital for six months. Patients aged 18 years and above and taking two or more drugs were included in the study. Medscape drug interaction checker was used to identify and analyze the pattern of potential DDI.

Results: Out of 500 patients, most of the patients were male (78.4%) in the age group of 50-60 years (31%). The most common diagnosis was acute coronary syndrome (57.2%). Out of total 2849 DDI, 2194 (77.01%) were pharmacodynamic, 586 (20.57%) were pharmacokinetic in nature while 69 (2.42%) drug pairs interacted by unknown mechanism. Majority of drug interactions were significant {2031 (71.29%)} in nature followed by minor {725(25.45%)} while serious drug interactions were observed in only 93 (3.26%) drug pairs. A positive correlation was observed between patientís age and number of drugs prescribed (r=0.178, p<0.001), number of drugs prescribed and potential Drug-Drug Interaction (pDDI) (r= 0.788, p<0.001) and between patientís age and pDDI (r=0.338, p<0.001).

Conclusion: The risk of pDDI was more commonly observed in elderly male patients particularly with antiplatelet drugs like low dose aspirin and clopidogrel.